The evolution of health policy guidelines for assisted reproduction in the Republic of Ireland, 2004-2009 by Walsh, David J et al.
COMMENTARY Open Access
The evolution of health policy guidelines for
assisted reproduction in the Republic of Ireland,
2004-2009
David J Walsh, Mary L Ma and Eric Scott Sills
*
Abstract
This analysis reports on Irish regulatory policies for in vitro fertilisation (IVF) from 2004-2009, in the context of
membership changes within the Medical Council of Ireland. To achieve this, the current (2009) edition of the Guide
to Professional Conduct & Ethics was compared with the immediately preceding version (2004). The statutory
composition of the Medical Council from 2004-2009 was also studied. Content analysis of the two editions
identified the following differences: 1) The 2004 guide states that IVF “should only be used after thorough
investigation has failed to reveal a treatable cause of the infertility”, while the 2009 guide indicates IVF “should only
be used after thorough investigation has shown that no other treatment is likely to be effective"; 2) The 2004
stipulation stating that fertilized ovum (embryo) “must be used for normal implantation and must not be
deliberately destroyed” is absent from the 2009 guidelines; 3) The option to donate “unused fertilised ova”
(embryos) is omitted from the 2009 guidelines; 4) The 2009 guidelines state that ART should be offered only by
“suitably qualified professionals, in appropriate facilities, and according to the international best practice"; 5) The
2009 guidelines introduce criteria that donations as part of a donor programme should be “altruistic and
non-commercial”. These last two points represent original regulatory efforts not appearing in the 2004 edition.
The Medical Practitioners Act 2007 reduced the number of physicians on the Medical Council to 6 (of 25)
members. The ethical guidelines from 2004 preceded this change, while the reconstituted Medical Council
published the 2009 version. Between 2004 and 2009, substantial modifications in reproductive health policy were
incorporated into the Medical Council’s ethical guidelines. The absence of controlling Irish legislation means that
patients and IVF providers in Ireland must rely upon these guidelines by default. Our critique traces the evolution
of public policy on IVF during a time when the membership of the Medical Council changed radically; reduced
physician contribution to decision-making was associated with diminished protection for IVF-derived embryos in
Ireland. Considerable uncertainty on IVF practice in Ireland remains.
Introduction
At present, there is no legislation specifically regulating
assisted reproductive technology (ART) in the Republic
of Ireland [1]. While the need for a statutory framework
to address the provision of ART in Ireland was acknowl-
edged by the Commission on Assisted Human Repro-
duction (CAHR) in 2005 [2] as well as the Irish
judiciary in 2009 [3], the Parliament of the Republic of
Ireland (the Oireachtas) has yet to enact any relevant
statutes.
In the absence of controlling legislation addressing
IVF, the only guidance medical practitioners in Ireland
currently have on assisted fertility matters is provided
by The Guide to Professional Conduct & Ethics for Regis-
tered Medical Practitioners (the “ethical guide”). The
version currently in effect is the most recent edition
published in 2009 [4], while the immediately preceding
edition appeared in 2004 [5]. These guides are periodi-
cally issued by the Medical Council, which is the central
medical registration authority in Ireland. With a remit
covering all medical practitioners throughout Ireland
and not just those engaged in the practice of reproduc-
tive medicine, the council’s guidelines must provide gui-
dance across the full range of medical practice. In this
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emphasis on how the council’sp o s i t i o no nA R Th a s
evolved between 2004 and 2009, on how the council
incorporated recommendations from the CAHR into its
2009 guidelines, and how the council’s own membership
changed between 2004 and 2009.
Discussion
Medical Council ethical guidelines 2004 and 2009:
Content analysis
The sixth (2004) edition of the Medical Council’s ethical
guidelines allocated 162 words to the area of ART,
touching upon cryopreservation, donation, and IVF [5].
In contrast, the seventh (2009) edition devoted 149
words to the topic of assisted fertility [4]. At least four
concepts central to the advanced reproductive technolo-
gies found different expression in these guidelines
between 2004 and 2009 (see Table 1).
1. IVF indications
The council’s 2004 guidelines indicate that IVF “should
only be used after thorough investigation has failed to
reveal a treatable cause of the infertility” [5]. In contrast,
the 2009 guidelines describe IVF as a treatment which
“should only be used after thorough investigation has
shown that no other treatment is likely to be effective”
[4]. While both versions encourage thorough diagnostic
investigations, the 2004 guidelines suggest that IVF
should be essentially limited to unexplained infertility.
This position had changed by 2009, where IVF was
regarded as best applied when “no other treatment is
likely to be effective” in 2009.
This modification has potentially serious implications
for patient choice regarding elective fertility treatment.
For example, there are instances where a non-IVF treat-
ment might be considered by a patient, but the alternate
approach would be much less effective than IVF. No
provision for this circumstance is made by Medical
Council guidelines. Is it “appropriate practice” to pro-
vide IVF for an older patient who simply wishes to
access IVF first, because it is the fertility treatment most
likely to be effective [6]? As the Medical Council’s
guidelines are presently configured, a violation would
seem likely in such a case. It is unclear why the Medical
Council would seek this level of control over a realm of
patient management not seen in other areas of Irish
clinical medicine.
2. Status and fate of human embryos
In 2004, Medical Council guidelines stipulated that ferti-
lised ovum/embryos “must be used for normal implanta-
tion and must not be deliberately destroyed” [5].
Interestingly, this proscription against deliberate embryo
destruction is missing from the Medical Council’s 2009
guidelines [4]. Since the 2004 restriction is removed–but
not replaced by any clarifying language–in the 2009
edition, the matter is left for individual practitioners to
determine what should be done with non-transferred
(surplus) embryos in Ireland.
Similarly, Medical Council guidelines specifically per-
mitted the donation of unused, surplus embryos to
other recipients in 2004, yet this “option to donate” was
retracted in the council’s 2009 guidelines [4]. Although
there is mention of “donor programmes” which may be
offered to patients, this is not described further. Similar
wording used in the 2004 guidelines suggests that these
donor programmes may in fact refer to sperm and ova
donation, rather than embryos. Taken together, these
two modifications significantly reconfigure public health
policy on non-transferred embryos from IVF, such that
embryo destruction is presently favoured over embryo
donation. This is because the 2009 guidelines make it
easier for Irish IVF clinics to destroy human embryos,
while at the same time, make it harder to organise
donation of surplus embryos to suitable recipients (i.e.,
other infertile couples) [7].
3. Credentials, facilities and standards
In a major departure from the 2004 edition, the coun-
cil’s 2009 guidelines specify that ART should be pro-
vided only by “suitably qualified professionals, in
appropriate facilities, and according to the international
best practice” [4]. While this is a new emphasis on
accreditation, the council did not articulate exactly what
qualifications and/or experience is necessary to meet
this standard either for Irish-trained IVF practitioners,
or for those trained in other jurisdictions who may seek
to practice here. At present, the Medical Council relies
on the RCPI’s Institute of Obstetricians & Gynaecolo-
gists to accredit general obstetricians & gynaecologists
[8]. The Institute has not established how it will evaluate
practice or accreditation issues that are limited to the
sub-specialty area of fertility medicine/surgery [9].
Equally, the council does not explain how patients or
doctors can know if an IVF clinic is operating in “appro-
priate facilities”, what agency will inspect such premises,
or how “appropriate” status should be determined and
validated. The Medical Council did not sanction the
current statutory oversight that already exists over Irish
IVF units by the Irish Medicines Board [10], but pro-
posed no specific alternative. The reference to “interna-
tional best practice” is non-descriptive and
unenforceable in the absence of additional refinement
(e.g., who defines this standard?).
4. Gamete donation
Current (2009) Medical Council guidelines state that
donations which are part of a donor programme should
be “altruistic and non-commercial” [4]. This aspect of
the guidelines represents a new level of regulatory con-
trol over IVF in Ireland. A wide variation currently
exists throughout the E.U. concerning the terms and
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Ireland, as issued by the Commission for Assisted Human Reproduction and the Medical Council
Policy issue 6
th Edition ethical guide
a 7
th Edition ethical guide
b CAHR
c
Agency,
accreditation,
and data
tracking
[none] 20.2 Assisted reproduction services should
only be provided by suitably qualified
professionals, in appropriate facilities, and
according to international best practice.
Regular clinical audit and follow-up of
outcomes should be the norm.
1. A regulatory body should be established
by an Act of the Oireachtas to regulate
AHR services in Ireland.
2. National statistics on the outcome of
AHR techniques in Ireland should be
compiled and made available to the
public.
3. Longitudinal studies of children born as
a result of AHR should be established, in
accordance with standard ethical/legal
requirements and with the consent of
families, in order to facilitate long-term
monitoring.
Gamete
donation
24.4 [...] Doctors who consider assisting
with donation to a third party must have
regard to the biological difficulties
involved, and pay meticulous attention to
the source of the donated material.
24.5 [...] If couples have validly decided
they do not wish to make use of their
own fertilised ova, the potential for
voluntary donation to other recipients
may be considered.
20.3 If you offer donor programmes to
patients, you must consider the biological
difficulties involved and pay particular
attention to the source of the donated
material. Such donations should be
altruistic and non-commercial. You should
keep accurate records for future reference.
10. Appropriate guidelines should be put
in place by the regulatory body to govern
the options available for excess frozen
embryos. These would include voluntary
donation of excess healthy embryos to
other recipients, voluntary donation for
research or allowing them to perish.
19. Donation of sperm, ova and embryos
should be permitted and should be
subject to regulation by the regulatory
body.
21. Appropriate guidelines should be put
in place to govern the selection of donors;
to screen for genetic disorders and
infectious disease; to set age limits for
donors and to set an appropriate limit on
the number of children to be born by the
use of sperm or ova from a single donor.
23. Donors should not be paid nor should
recipients be charged for donations per se.
This does not preclude payment of
reasonable expenses and payment for AHR
services.
Counselling 24.5 [...] Prior to fertilisation of an ovum,
extensive discussion and counseling is
essential.
20.1 [...] You should ensure that
appropriate counseling has been offered
to the patient [...]
12. Counselling should be provided before,
during and after treatment to those
considering AHR treatment so that they
are adequately informed of the risks
involved, the potential benefits that may
be obtained, and the possibility of success
in their particular situation. Suitably
qualified professionals should adequately
convey the complex medical and scientific
ramifications of different treatment
approaches in verbal and written form.
Embryo
destruction
24.5 [...] Any fertilised ovum must be used
for normal implantation and must not be
deliberately destroyed.
[Repealed] 10. Appropriate guidelines should be put
in place by the regulatory body to govern
the options available for excess frozen
embryos. These would include [...] allowing
them to perish.
IVF
indications
24.5 Techniques such as IVF should only
be used after thorough investigation has
failed to reveal a treatable cause for the
infertility.
20.1 Assisted human reproduction
treatments, such as IVF, should only be
used after thorough investigation has
shown that no other treatment is likely to
be effective.
17. Services should be available without
discrimination on the grounds of gender,
marital status or sexual orientation subject
to consideration of the best interests of
any children that may be born. Any
relevant legislation on the provision of
AHR services should reflect the general
principles of the Equal Status Acts 2000-4
subject to the qualifications set out in
section 4.8.
Notes: AHR = assisted human reproduction, IVF = in vitro fertilisation, fertilised ovum = embryo.
a A Guide to Ethical Conduct and Behaviour, 6
th Edition. Medical Council. Dublin 2004:1-44.
b Guide to Professional Conduct and Ethics for Registered Medical Practitioners, 7
th Edition. Medical Council. Dublin 2009:1-61.
c Report of the Commission on Assisted Reproduction (2005). Government of Ireland Publications: Dublin; 2005.
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legal requirements in each jurisdiction [11-13]. Research
elsewhere has found that nominal compensatory pay-
ment to gamete donors does not negate the altruistic
motive for donation [14]. How this principle should be
applied in Ireland remains unsettled [10] because the
2009 guidelines do not specify terms and conditions for
gamete donor compensation in Ireland. The closely
allied social issue of donor privacy (i.e.a n o n y m o u s
donation) [15-17] was not addressed in either the 2004
or the 2009 guidelines. While donor privacy was
addressed in the 2005 CAHR report, these findings were
not acknowledged by the Medical Council.
Medical Council membership dynamics, 2004-2009
The Medical Practitioners Act 2007, [18] included sig-
nificant changes for the Medical Council. Indeed, its
statutory composition changed radically as a direct
result of this legislation. The membership of the Medical
Council was to shift away from its historic roster of phy-
sicians, to a new model where most of the council
would not be medical professionals. Specifically, the
2007 Act required that of its 25 members, 9 appointees
specifically must fulfil the criteria of “not and never
[having] been a medical practitioner in the State or in
another jurisdiction”. Other parts of the 2007 Act
brought the total number of “practicing physician”
members on the council to six (of 25), resulting in an
unusual “medical minority” [19] among Ireland’sM e d i -
cal Council. Accordingly, the council’s 2004 and 2009
ethical guidelines were authorised and issued by Medical
Councils with very different memberships.
The CAHR: a largely discarded resource?
The Commission for Assisted Human Reproduction
(CAHR) was established by government mandate in
2000; its comprehensive report was published in 2005.
This cross-disciplinary panel of experts was charged with
the task of creating a report on the “possible approaches
to the regulation of all aspects of assisted human repro-
duction and the social, ethical and legal factors to be
taken into account in determining public policy in the
area”. The result was a 151-page document covering
potential ethical issues, sampling Irish public opinion,
providing a list of recommendations covering all areas of
assisted reproduction, exploring dissent of opinions
among commission members, and comparing similar
guidelines among other countries [2]. This report focused
exclusively on assisted fertility policy in Ireland in con-
cert with the medical registration work of the Medical
Council; indeed, the commission’s landmark report was
issued the year following the council’s 2004 guidelines.
While the CAHR report proposed 40 recommenda-
tions specifically addressing reproductive health policy
in Ireland, the Medical Council applied only four of
these to their 2009 guidelines. These four recommenda-
tions were in aspects of accreditation and gamete dona-
tion. Perhaps not surprisingly, the first recommendation
set forth by the CAHR was that a “regulatory body
should be established by an Act of the Oireachtas to
regulate [assisted fertility] services in Ireland”.S u c ha
regulatory body would have responsibility for issuing
licences for using ART in a clinical, laboratory, storage
or research faculty. In Section 202 of the 2009 Medical
Council guidelines, such language from the CAHR
report appears to have helped shape the council’s
recommendation for “suitably qualified professionals, in
appropriate facilities”. Additionally, this section of the
2009 guidelines incorporated the CAHR recommenda-
tion concerning national statistics and longitudinal stu-
dies by proposing that the “follow-up of outcomes
should be the norm”. Likewise, the CAHR recommenda-
tion that “donors should not be paid nor should recipi-
ents be charged for donations” excluding costs directly
related to ART services, also appears in the 2009 guide-
lines. No other components of the CAHR report were
accessioned into the IMC’s 2009 guidelines.
Conclusions
Ireland, Poland and Romania are the only E.U. member
states without formal regulation for IVF and related
assisted fertility treatments [20]. As the number of IVF
cycles initiated in Ireland continues to rise, the lack of
comprehensive national legislation covering assisted
reproductive treatments presents a health policy pro-
blem of significant dimensions. Even though no orga-
nised group has ever advocated the continued
unregulated status of fertility treatments in Ireland, the
entire topic has proven sufficiently contentious that no
one has succeeded in overcoming the inertia of inaction.
The resulting neglect of the issue by the Oireachtas has
effectively handed the Medical Council a regulatory
blank canvas, empowering the council to develop its
own rules for IVF in Ireland. Our analysis concludes
that the council has only partially actualised this oppor-
tunity at present.
How the Medical Council has chosen to manage regu-
lation of the assisted fertility portfolio brings important
consequences for Irish patients, their families, and their
children-those present and those yet to be born. From a
public policy perspective, the changes in Medical Coun-
cil guidelines regarding when IVF should be used and
what may happen to surplus embryos illustrate distinctly
inconsistent regulatory themes. This is because the for-
mer case actively limits how physicians decide when an
elective medical procedure should be performed, while
the latter case passively enlarges the range of options for
physicians regarding surplus IVF embryos. Against this
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to clarify their regulatory objectives with respect to how
they think IVF should be provided in Ireland.
Our assessment of the evolution of Medical Council
guidelines for assisted fertility treatments between 2004
and 2009 finds some areas of positive change for Ire-
land. These would include the council’s support for
improved accreditation, record keeping, and audit. How-
ever, other modifications in the ethical guidelines (if
strictly interpreted) could restrict or impair access to
IVF at a time where demand for such treatment is
increasing in Ireland. That the council distanced itself
from the key dilemma of what to do with surplus (non-
transferred) frozen embryos between 2004 and 2009 was
an unexpected finding of this analysis. While the 2004
guidelines stated that embryos must not be deliberately
destroyed, those same guidelines did recognise the
option of potential donation to other individuals [5].
Curiously, the 2009 guidelines are now silent as to what
c a nb ed o n ew i t he x c e s se m b r y o si nI r e l a n d[ 4 ] .W h a t -
ever protections these embryos may have had in 2004,
the Medical Council considerably weakened such pro-
tection by 2009. While the sponsors of the Medical
Practitioners Act, 2007 may not have intended embryos
from IVF to be more vulnerable after the required
membership reorganisation at the Medical Council, cur-
rent (2009) practice guidelines have achieved this very
e f f e c t .I ti sa l s oi m p o s s i b l et ok n o wi ft h i se r o s i o no f
protection for IVF embryos would have happened if the
Medical Council had retained its medical majority com-
position, but this seems unlikely based on its historically
“pro life” ethical emphasis.
Recent research has underscored the complexities
associated with donor compensation and privacy [21,22],
as well as embryo disposition [10,23] and abandonment
[24] in Ireland. It is disappointing that none of these
important issues were explored in the 2009 guidelines.
We agree with the CAHR report that the ultimate
responsibility for regulation of assisted fertility services
in Ireland rests with the Oireachtas [25,26]. But by now,
the Medical Council may need to confront the uncom-
fortable possibility that the Oireachtas might never
achieve this. Indeed even if it does enact such legisla-
tion, many years could pass in the process. In the mean-
time, we continue our endorsement of the Medical
Council’s statement (appearing in the Introduction to
their current 2009 guidelines) that comprehensive guide-
lines must be developed to address the issues high-
lighted here.
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